Diagnosis and management of human parvovirus B19 infection

Mildred M Ramirez; Joan M Mastrobattista

doi:10.1016/j.clp.2005.04.003

Diagnosis and management of human parvovirus B19 infection

Clin Perinatol. 2005 Sep;32(3):697-704. doi: 10.1016/j.clp.2005.04.003.

Authors

Mildred M Ramirez¹, Joan M Mastrobattista

Affiliation

¹ Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Texas Health Science Center at Houston, Houston, TX 77030, USA. mildred.m.ramirez@uth.tmc.edu

PMID: 16085027
DOI: 10.1016/j.clp.2005.04.003

Abstract

Parvovirus B19 is a common infection in children occurring in winter and spring months that can affect pregnant women and their unborn fetuses. Adverse fetal sequelae may include red blood cell aplasia due to bone marrow suppression, anemia, myocarditis, nonimmune hydrops, and fetal death. Fortunately, several noninvasive testing schemes are available to assess the fetus, and invasive testing is reserved for fetuses with marked anemia.

Publication types

Review

MeSH terms

Antibodies, Viral / analysis
DNA, Viral / analysis
Female
Humans
Parvoviridae Infections* / diagnosis
Parvoviridae Infections* / therapy
Parvovirus B19, Human / genetics*
Parvovirus B19, Human / immunology
Pregnancy
Pregnancy Complications, Infectious* / diagnosis
Pregnancy Complications, Infectious* / therapy
Prenatal Care / methods*
Prenatal Diagnosis / methods*
Time Factors

Substances

Antibodies, Viral
DNA, Viral